HEADER VIRAL PROTEIN/VIRAL PROTEIN INHIBITOR 06-OCT-16 5H0N TITLE CRYSTAL STRUCTURE OF HIV-1 FUSION INHIBITOR MT-WQ-IDL BOUND TO GP41 TITLE 2 NHR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 GP41 NHR; COMPND 3 CHAIN: A, C, E, G, I, K; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HIV-1 FUSION INHIBITOR MT-WQ-IDL; COMPND 7 CHAIN: B, D, F, H, J, L; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 8 ORGANISM_TAXID: 11676 KEYWDS MT-WQ-IDL, HIV-1, FUSION INHIBITOR, VIRAL PROTEIN-VIRAL PROTEIN KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHU,S.YE,R.ZHANG REVDAT 4 08-NOV-23 5H0N 1 REMARK REVDAT 3 22-NOV-17 5H0N 1 JRNL REVDAT 2 27-SEP-17 5H0N 1 JRNL REMARK REVDAT 1 02-NOV-16 5H0N 0 JRNL AUTH S.SU,Y.ZHU,S.YE,Q.QI,S.XIA,Z.MA,F.YU,Q.WANG,R.ZHANG,S.JIANG, JRNL AUTH 2 L.LU JRNL TITL CREATING AN ARTIFICIAL TAIL ANCHOR AS A NOVEL STRATEGY TO JRNL TITL 2 ENHANCE THE POTENCY OF PEPTIDE-BASED HIV FUSION INHIBITORS JRNL REF J. VIROL. V. 91 2017 JRNL REFN ESSN 1098-5514 JRNL PMID 27795416 JRNL DOI 10.1128/JVI.01445-16 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.6 REMARK 3 NUMBER OF REFLECTIONS : 12009 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.280 REMARK 3 FREE R VALUE TEST SET COUNT : 634 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.6219 - 4.7858 0.81 2220 128 0.2514 0.3018 REMARK 3 2 4.7858 - 3.7996 0.84 2246 127 0.2028 0.2209 REMARK 3 3 3.7996 - 3.3196 0.87 2310 137 0.2422 0.2852 REMARK 3 4 3.3196 - 3.0162 0.85 2284 113 0.2588 0.3099 REMARK 3 5 3.0162 - 2.8001 0.87 2315 129 0.2673 0.3283 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.340 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3716 REMARK 3 ANGLE : 0.465 4988 REMARK 3 CHIRALITY : 0.035 571 REMARK 3 PLANARITY : 0.002 623 REMARK 3 DIHEDRAL : 21.457 1448 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5H0N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1300001805. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97853 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12009 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 39.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.6 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 5CMZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M ZINC ACETATE, 0.1 M IMIDAZOLE: REMARK 280 HCL PH 8.0, 20% (V/V) 1,4-BUTANEDIOL, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.61800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -100.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -95.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, I, J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 2 REMARK 465 LEU A 3 REMARK 465 THR A 4 REMARK 465 VAL A 5 REMARK 465 GLN A 6 REMARK 465 LEU A 47 REMARK 465 THR C 2 REMARK 465 LEU C 3 REMARK 465 THR C 4 REMARK 465 LEU C 47 REMARK 465 LEU D 82 REMARK 465 THR E 2 REMARK 465 LEU E 3 REMARK 465 LEU E 47 REMARK 465 LEU F 82 REMARK 465 THR G 2 REMARK 465 LEU G 47 REMARK 465 LEU H 82 REMARK 465 THR I 2 REMARK 465 LEU I 47 REMARK 465 THR K 2 REMARK 465 LEU K 3 REMARK 465 LEU K 47 REMARK 465 LEU L 82 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N MET D 52 O HOH D 101 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CD2 LEU J 82 O HOH D 101 2455 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 81 42.63 -79.68 REMARK 500 ARG C 8 -72.42 -53.67 REMARK 500 ILE D 80 70.27 -69.64 REMARK 500 ILE F 80 -7.52 -58.59 REMARK 500 VAL G 5 79.66 -151.28 REMARK 500 GLN K 6 56.01 -94.13 REMARK 500 ILE L 80 22.08 -72.61 REMARK 500 REMARK 500 REMARK: NULL DBREF 5H0N A 2 47 PDB 5H0N 5H0N 2 47 DBREF 5H0N B 52 82 PDB 5H0N 5H0N 52 82 DBREF 5H0N C 2 47 PDB 5H0N 5H0N 2 47 DBREF 5H0N D 52 82 PDB 5H0N 5H0N 52 82 DBREF 5H0N E 2 47 PDB 5H0N 5H0N 2 47 DBREF 5H0N F 52 82 PDB 5H0N 5H0N 52 82 DBREF 5H0N G 2 47 PDB 5H0N 5H0N 2 47 DBREF 5H0N H 52 82 PDB 5H0N 5H0N 52 82 DBREF 5H0N I 2 47 PDB 5H0N 5H0N 2 47 DBREF 5H0N J 52 82 PDB 5H0N 5H0N 52 82 DBREF 5H0N K 2 47 PDB 5H0N 5H0N 2 47 DBREF 5H0N L 52 82 PDB 5H0N 5H0N 52 82 SEQRES 1 A 46 THR LEU THR VAL GLN ALA ARG GLN LEU LEU SER GLY ILE SEQRES 2 A 46 VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA ILE GLU ALA SEQRES 3 A 46 GLN GLN HIS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 A 46 GLN LEU GLN ALA ARG ILE LEU SEQRES 1 B 31 MET THR TRP GLU GLU TRP ASP LYS LYS ILE GLU GLU TYR SEQRES 2 B 31 THR LYS LYS ILE GLU GLU LEU ILE LYS LYS SER GLN ASN SEQRES 3 B 31 GLN GLN ILE ASP LEU SEQRES 1 C 46 THR LEU THR VAL GLN ALA ARG GLN LEU LEU SER GLY ILE SEQRES 2 C 46 VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA ILE GLU ALA SEQRES 3 C 46 GLN GLN HIS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 C 46 GLN LEU GLN ALA ARG ILE LEU SEQRES 1 D 31 MET THR TRP GLU GLU TRP ASP LYS LYS ILE GLU GLU TYR SEQRES 2 D 31 THR LYS LYS ILE GLU GLU LEU ILE LYS LYS SER GLN ASN SEQRES 3 D 31 GLN GLN ILE ASP LEU SEQRES 1 E 46 THR LEU THR VAL GLN ALA ARG GLN LEU LEU SER GLY ILE SEQRES 2 E 46 VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA ILE GLU ALA SEQRES 3 E 46 GLN GLN HIS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 E 46 GLN LEU GLN ALA ARG ILE LEU SEQRES 1 F 31 MET THR TRP GLU GLU TRP ASP LYS LYS ILE GLU GLU TYR SEQRES 2 F 31 THR LYS LYS ILE GLU GLU LEU ILE LYS LYS SER GLN ASN SEQRES 3 F 31 GLN GLN ILE ASP LEU SEQRES 1 G 46 THR LEU THR VAL GLN ALA ARG GLN LEU LEU SER GLY ILE SEQRES 2 G 46 VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA ILE GLU ALA SEQRES 3 G 46 GLN GLN HIS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 G 46 GLN LEU GLN ALA ARG ILE LEU SEQRES 1 H 31 MET THR TRP GLU GLU TRP ASP LYS LYS ILE GLU GLU TYR SEQRES 2 H 31 THR LYS LYS ILE GLU GLU LEU ILE LYS LYS SER GLN ASN SEQRES 3 H 31 GLN GLN ILE ASP LEU SEQRES 1 I 46 THR LEU THR VAL GLN ALA ARG GLN LEU LEU SER GLY ILE SEQRES 2 I 46 VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA ILE GLU ALA SEQRES 3 I 46 GLN GLN HIS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 I 46 GLN LEU GLN ALA ARG ILE LEU SEQRES 1 J 31 MET THR TRP GLU GLU TRP ASP LYS LYS ILE GLU GLU TYR SEQRES 2 J 31 THR LYS LYS ILE GLU GLU LEU ILE LYS LYS SER GLN ASN SEQRES 3 J 31 GLN GLN ILE ASP LEU SEQRES 1 K 46 THR LEU THR VAL GLN ALA ARG GLN LEU LEU SER GLY ILE SEQRES 2 K 46 VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA ILE GLU ALA SEQRES 3 K 46 GLN GLN HIS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 K 46 GLN LEU GLN ALA ARG ILE LEU SEQRES 1 L 31 MET THR TRP GLU GLU TRP ASP LYS LYS ILE GLU GLU TYR SEQRES 2 L 31 THR LYS LYS ILE GLU GLU LEU ILE LYS LYS SER GLN ASN SEQRES 3 L 31 GLN GLN ILE ASP LEU FORMUL 13 HOH *7(H2 O) HELIX 1 AA1 GLN A 9 ALA A 44 1 36 HELIX 2 AA2 THR B 53 GLN B 78 1 26 HELIX 3 AA3 ALA C 7 ARG C 45 1 39 HELIX 4 AA4 THR D 53 ILE D 80 1 28 HELIX 5 AA5 VAL E 5 ALA E 44 1 40 HELIX 6 AA6 THR F 53 ILE F 80 1 28 HELIX 7 AA7 GLN G 6 GLN G 43 1 38 HELIX 8 AA8 THR H 53 ILE H 80 1 28 HELIX 9 AA9 THR I 4 ILE I 46 1 43 HELIX 10 AB1 THR J 53 GLN J 78 1 26 HELIX 11 AB2 ALA K 7 ALA K 44 1 38 HELIX 12 AB3 THR L 53 ILE L 80 1 28 CRYST1 55.417 79.236 70.936 90.00 111.24 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018045 0.000000 0.007015 0.00000 SCALE2 0.000000 0.012621 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015125 0.00000